![Second Opinion artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/da/a5/a0/daa5a0bb-9c42-d0aa-7acb-acdf5b1d20a4/mza_2076809052937298310.png/100x100bb.jpg)
Marketing low value products
Second Opinion
English - June 06, 2021 13:35 - 4 minutes - 3.31 MB - ★★★★★ - 62 ratingsArts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Using incentives to drive health care
Next Episode: Mistaken approval of Alzheimer’s Drug
If COVID-19 has taught us anything, one lesson is that we need to rethink allowing promotions for treatments that are overdone, unnecessary, or not proven effective.